These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6595458)

  • 1. Issues in the design and conduct of clinical trials.
    Hennekens CH
    J Natl Cancer Inst; 1984 Dec; 73(6):1473-6. PubMed ID: 6595458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers of compliance in the Physicians' Health Study.
    Satterfield S; Greco PJ; Goldhaber SZ; Stampfer MJ; Swartz SL; Stein EA; Kaplan L; Hennekens CH
    Am J Prev Med; 1990; 6(5):290-4. PubMed ID: 2268456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline characteristics of participants in the Physicians' Health Study: a randomized trial of aspirin and beta-carotene in U.S. physicians.
    Manson JE; Buring JE; Satterfield S; Hennekens CH
    Am J Prev Med; 1991; 7(3):150-4. PubMed ID: 1931143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group.
    Taylor PR; Li B; Dawsey SM; Li JY; Yang CS; Guo W; Blot WJ
    Cancer Res; 1994 Apr; 54(7 Suppl):2029s-2031s. PubMed ID: 8137333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers.
    Goodman GE; Omenn GS; Thornquist MD; Lund B; Metch B; Gylys-Colwell I
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):389-96. PubMed ID: 8348063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of human trial design.
    Buiatti E
    IARC Sci Publ; 1996; (139):261-9. PubMed ID: 8923036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary report on the results of nutrition prevention trials of cancer and other common diseases among residents in Linxian, China].
    Li JY; Li B; Blot WJ; Taylor PR
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):165-81. PubMed ID: 8261860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers.
    Omenn GS; Goodman GE; Thornquist MD; Rosenstock L; Barnhart S; Gylys-Colwell I; Metch B; Lund B
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):381-7. PubMed ID: 8348062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current issues in non-inferiority trials.
    Fleming TR
    Stat Med; 2008 Feb; 27(3):317-32. PubMed ID: 17340597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and efficiency in clinical trials: the U.S. Physicians' Health Study.
    Buring JE; Hennekens CH
    Stat Med; 1990; 9(1-2):29-33. PubMed ID: 2345836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians.
    Stampfer MJ; Buring JE; Willett W; Rosner B; Eberlein K; Hennekens CH
    Stat Med; 1985; 4(2):111-6. PubMed ID: 4023472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.
    Gent M; Barnett HJ; Sackett DL; Taylor DW
    Circulation; 1980 Dec; 62(6 Pt 2):V97-105. PubMed ID: 7002357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of aspirin and beta-carotene among U.S. physicians.
    Hennekens CH; Eberlein K
    Prev Med; 1985 Mar; 14(2):165-8. PubMed ID: 3900975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current issues in cancer chemoprevention.
    Buring JE; Hennekens CH
    IARC Sci Publ; 1990; (103):185-93. PubMed ID: 2279796
    [No Abstract]   [Full Text] [Related]  

  • 19. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
    Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
    J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.